Book contents
- Neuromuscular Disease: A Case-Based Approach
- Neuromuscular Disease
- Copyright page
- Contents
- Contributors
- Foreword
- Preface to 2nd Edition
- Part I Evaluation and Treatment of Patients with a Neuromuscular Disorder
- Part II Neuromuscular Cases
- Disorders of the Anterior Horn Cell
- Peripheral Neuropathies
- Case 9 Guillain–Barré Syndrome (GBS) and Miller–Fisher Syndrome (MFS)
- Case 10 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Case 11 IgM Anti-MAG Polyneuropathy
- Case 12 Polyneuropathy, Organomegaly, Endocrine Manifestations, Monoclonal Protein, and Skin Changes (POEMS) Syndrome
- Case 13 Vasculitic Neuropathy
- Case 14 Small-Fibre Neuropathy (SFN)
- Case 15 Sensory Neuronopathy (SNN, Ganglionopathy)
- Case 16 Wartenberg Migrant Sensory Neuropathy
- Case 17 Multifocal Motor Neuropathy (MMN)
- Case 18 Peripheral Nerve Hyperexcitability Syndromes: Morvan Syndrome
- Case 19 Idiopathic Brachial Plexus Neuropathy, Neuralgic Amyotrophy (NA)
- Case 20 Diabetic Neuropathy
- Case 21 Alcoholic Polyneuropathy
- Case 22 Chronic Idiopathic Axonal Polyneuropathy (CIAP)
- Case 23 Critical Illness Polyneuropathy and Myopathy (CIPM)
- Case 24 Drug-Induced Polyneuropathies: Amiodarone Polyneuropathy
- Case 25 Lyme Radiculopathy
- Case 26 Leprosy
- Case 27 Charcot–Marie–Tooth Disease (CMT) Type 1A/Hereditary Neuropathy with Liability for Pressure Palsies (HNPP)
- Case 28 Charcot–Marie–Tooth Disease (CMT) Type 2 A and Type 2B
- Case 29 Hereditary Sensory and Autonomic Neuropathy (HSAN) Type 4
- Case 30 Hereditary Transthyretin (TTR) Amyloidosis
- Disorders of the Neuromuscular Junction
- Myopathies
- Video legends
- Index
- References
Case 11 - IgM Anti-MAG Polyneuropathy
from Peripheral Neuropathies
Published online by Cambridge University Press: 29 November 2024
Book contents
- Neuromuscular Disease: A Case-Based Approach
- Neuromuscular Disease
- Copyright page
- Contents
- Contributors
- Foreword
- Preface to 2nd Edition
- Part I Evaluation and Treatment of Patients with a Neuromuscular Disorder
- Part II Neuromuscular Cases
- Disorders of the Anterior Horn Cell
- Peripheral Neuropathies
- Case 9 Guillain–Barré Syndrome (GBS) and Miller–Fisher Syndrome (MFS)
- Case 10 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Case 11 IgM Anti-MAG Polyneuropathy
- Case 12 Polyneuropathy, Organomegaly, Endocrine Manifestations, Monoclonal Protein, and Skin Changes (POEMS) Syndrome
- Case 13 Vasculitic Neuropathy
- Case 14 Small-Fibre Neuropathy (SFN)
- Case 15 Sensory Neuronopathy (SNN, Ganglionopathy)
- Case 16 Wartenberg Migrant Sensory Neuropathy
- Case 17 Multifocal Motor Neuropathy (MMN)
- Case 18 Peripheral Nerve Hyperexcitability Syndromes: Morvan Syndrome
- Case 19 Idiopathic Brachial Plexus Neuropathy, Neuralgic Amyotrophy (NA)
- Case 20 Diabetic Neuropathy
- Case 21 Alcoholic Polyneuropathy
- Case 22 Chronic Idiopathic Axonal Polyneuropathy (CIAP)
- Case 23 Critical Illness Polyneuropathy and Myopathy (CIPM)
- Case 24 Drug-Induced Polyneuropathies: Amiodarone Polyneuropathy
- Case 25 Lyme Radiculopathy
- Case 26 Leprosy
- Case 27 Charcot–Marie–Tooth Disease (CMT) Type 1A/Hereditary Neuropathy with Liability for Pressure Palsies (HNPP)
- Case 28 Charcot–Marie–Tooth Disease (CMT) Type 2 A and Type 2B
- Case 29 Hereditary Sensory and Autonomic Neuropathy (HSAN) Type 4
- Case 30 Hereditary Transthyretin (TTR) Amyloidosis
- Disorders of the Neuromuscular Junction
- Myopathies
- Video legends
- Index
- References
Summary
A 62-year-old man reported slowly progressive symptoms over a period of two years. He could no longer walk steadily and developed numb feelings on the soles of both feet and a tremor of both hands. He was not known to have diabetes and ate a healthy, balanced diet, drank one glass of alcohol a day, and had not been treated with neurotoxic medication.
- Type
- Chapter
- Information
- Neuromuscular DiseaseA Case-Based Approach, pp. 99 - 103Publisher: Cambridge University PressPrint publication year: 2024
References
Suggested Reading
Carroll, AS, Lunn, MPT. Paraproteinaemic neuropathy: MGUS and beyond. Pract Neurol 2021;21(6):492–503. doi: 10.1136/practneurol-2020-002837. Epub 2021 Jul 19. PMID: 34282034.CrossRefGoogle ScholarPubMed
Chaganti, S, Hannaford, A, Vucic, S. Rituximab in chronic immune mediated neuropathies: a systematic review. Neuromuscul Disord 2022;32(8):621–627. doi: 10.1016/j.nmd.2022.05.013. Epub 2022 May 24. PMID: 35672205.CrossRefGoogle ScholarPubMed
Lunn, MP, Nobile-Orazio, E. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev 2016;10(10):CD002827. doi: 10.1002/14651858.CD002827.pub4. PMID: 27701752; PMCID: PMC6457998.Google ScholarPubMed
Parisi, M, Dogliotti, I, Clerico, M, et al. Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up. Eur J Neurol 2022;29(12):3611–3622. doi: 10.1111/ene.15553. Epub 2022 Sep 25. PMID: 36083713; PMCID: PMC9825860.CrossRefGoogle ScholarPubMed
Sommer, C, Carroll, AS, Koike, H, et al. Nerve biopsy in acquired neuropathies. J Peripher Nerv Syst 2021;26 Suppl 2:S21–S41. doi: 10.1111/jns.12464. Epub 2021 Sep 14. PMID: 34523188.CrossRefGoogle ScholarPubMed
Taams, NE, Drenthen, J, Hanewinckel, R, Ikram, MA, van Doorn, PA. Prevalence and risk factor profiles for chronic axonal polyneuropathy in the general population. Neurology 2022:10.1212/WNL.0000000000201168. doi: 10.1212/WNL.0000000000201168. Epub ahead of print. PMID: 36008153.Google Scholar
Vallat, JM, Duchesne, M, Corcia, P, et al. The wide spectrum of pathophysiologic mechanisms of paraproteinemic neuropathy. Neurology 2021;96(5):214–225. doi: 10.1212/WNL.0000000000011324. Epub 2020 Dec 4. PMID: 33277411.CrossRefGoogle ScholarPubMed